Tuesday, September 25, 2018

Very High Importance!

Skip to main page content U.S. Food and Drug Administration Search FDA Submit search Popular Content Press Announcements FDA Statement Remarks from Anna Abram as prepared for delivery to the 2018 Intergovermental Meeting on Drug Compounding

 morning and welcome. I am Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis here at the Food and Drug Administration.

I would like to thank you all for traveling from near and far to be with us today to participate in our seventh intergovernmental meeting on drug compounding. Wherever you hail from, and whether this is your first or seventh meeting, we’re glad to have you join us to continue our ongoing dialogue about ways to reduce the risks associated with compounded drug products and improve collaboration between FDA and the states. We greatly value our work with you, and we feel strongly that our partnerships with you are critical to maintaining robust oversight of compounders to protect the public health.

Texas' First Free Pharmacy Opens in North Texas

NBC 5 Dallas-Fort Worth-4 hours ago
The Society of St. Vincent de Paul of North Texas has opened the first public free pharmacy in the state. The group soft launched the pilot pharmacy program ...

PhRMA unlikely to get Part D changes in opioid bill

Politico-21 hours ago
The branded drug lobby also is not anticipated to succeed in using the opioid bill to .... Compounded medicine blamed for serious vision problems — At least 68 ...

Ex-employees of pharmacy in meningitis outbreak win separate trials

Reuters-13 hours ago
A federal judge on Monday ruled that two pharmacists accused of helping fill fake prescriptions while working at a Massachusetts compounding pharmacy linked .